Cargando…
Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans
Nontargeted metabolomics methods have increased potential to identify new disease biomarkers, but assessments of the additive information provided in large human cohorts by these less biased techniques are limited. To diversify our knowledge of diabetes-associated metabolites, we leveraged a method...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630088/ https://www.ncbi.nlm.nih.gov/pubmed/35998269 http://dx.doi.org/10.2337/db22-0033 |
_version_ | 1784823526286426112 |
---|---|
author | Chen, Zsu-Zsu Pacheco, Julian Avila Gao, Yan Deng, Shuliang Peterson, Bennet Shi, Xu Zheng, Shuning Tahir, Usman A. Katz, Daniel H. Cruz, Daniel E. Ngo, Debby Benson, Mark D. Robbins, Jeremy M. Guo, Xiuqing del Rocio Sevilla Gonzalez, Magdalena Manning, Alisa Correa, Adolfo Meigs, James B. Taylor, Kent D. Rich, Stephen S. Goodarzi, Mark O. Rotter, Jerome I. Wilson, James G. Clish, Clary B. Gerszten, Robert E. |
author_facet | Chen, Zsu-Zsu Pacheco, Julian Avila Gao, Yan Deng, Shuliang Peterson, Bennet Shi, Xu Zheng, Shuning Tahir, Usman A. Katz, Daniel H. Cruz, Daniel E. Ngo, Debby Benson, Mark D. Robbins, Jeremy M. Guo, Xiuqing del Rocio Sevilla Gonzalez, Magdalena Manning, Alisa Correa, Adolfo Meigs, James B. Taylor, Kent D. Rich, Stephen S. Goodarzi, Mark O. Rotter, Jerome I. Wilson, James G. Clish, Clary B. Gerszten, Robert E. |
author_sort | Chen, Zsu-Zsu |
collection | PubMed |
description | Nontargeted metabolomics methods have increased potential to identify new disease biomarkers, but assessments of the additive information provided in large human cohorts by these less biased techniques are limited. To diversify our knowledge of diabetes-associated metabolites, we leveraged a method that measures 305 targeted or “known” and 2,342 nontargeted or “unknown” compounds in fasting plasma samples from 2,750 participants (315 incident cases) in the Jackson Heart Study (JHS)—a community cohort of self-identified African Americans—who are underrepresented in omics studies. We found 307 unique compounds (82 known) associated with diabetes after adjusting for age and sex at a false discovery rate of <0.05 and 124 compounds (35 known, including 11 not previously associated) after further adjustments for BMI and fasting plasma glucose. Of these, 144 and 68 associations, respectively, replicated in a multiethnic cohort. Among these is an apparently novel isomer of the 1-deoxyceramide Cer(m18:1/24:0) with functional geonomics and high-resolution mass spectrometry. Overall, known and unknown metabolites provided complementary information (median correlation ρ = 0.29), and their inclusion with clinical risk factors improved diabetes prediction modeling. Our findings highlight the importance of including nontargeted metabolomics methods to provide new insights into diabetes development in ethnically diverse cohorts. |
format | Online Article Text |
id | pubmed-9630088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-96300882023-01-21 Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans Chen, Zsu-Zsu Pacheco, Julian Avila Gao, Yan Deng, Shuliang Peterson, Bennet Shi, Xu Zheng, Shuning Tahir, Usman A. Katz, Daniel H. Cruz, Daniel E. Ngo, Debby Benson, Mark D. Robbins, Jeremy M. Guo, Xiuqing del Rocio Sevilla Gonzalez, Magdalena Manning, Alisa Correa, Adolfo Meigs, James B. Taylor, Kent D. Rich, Stephen S. Goodarzi, Mark O. Rotter, Jerome I. Wilson, James G. Clish, Clary B. Gerszten, Robert E. Diabetes Genetics/Genomes/Proteomics/Metabolomics Nontargeted metabolomics methods have increased potential to identify new disease biomarkers, but assessments of the additive information provided in large human cohorts by these less biased techniques are limited. To diversify our knowledge of diabetes-associated metabolites, we leveraged a method that measures 305 targeted or “known” and 2,342 nontargeted or “unknown” compounds in fasting plasma samples from 2,750 participants (315 incident cases) in the Jackson Heart Study (JHS)—a community cohort of self-identified African Americans—who are underrepresented in omics studies. We found 307 unique compounds (82 known) associated with diabetes after adjusting for age and sex at a false discovery rate of <0.05 and 124 compounds (35 known, including 11 not previously associated) after further adjustments for BMI and fasting plasma glucose. Of these, 144 and 68 associations, respectively, replicated in a multiethnic cohort. Among these is an apparently novel isomer of the 1-deoxyceramide Cer(m18:1/24:0) with functional geonomics and high-resolution mass spectrometry. Overall, known and unknown metabolites provided complementary information (median correlation ρ = 0.29), and their inclusion with clinical risk factors improved diabetes prediction modeling. Our findings highlight the importance of including nontargeted metabolomics methods to provide new insights into diabetes development in ethnically diverse cohorts. American Diabetes Association 2022-11 2022-08-23 /pmc/articles/PMC9630088/ /pubmed/35998269 http://dx.doi.org/10.2337/db22-0033 Text en © 2022 by the American Diabetes Association https://www.diabetesjournals.org/journals/pages/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. |
spellingShingle | Genetics/Genomes/Proteomics/Metabolomics Chen, Zsu-Zsu Pacheco, Julian Avila Gao, Yan Deng, Shuliang Peterson, Bennet Shi, Xu Zheng, Shuning Tahir, Usman A. Katz, Daniel H. Cruz, Daniel E. Ngo, Debby Benson, Mark D. Robbins, Jeremy M. Guo, Xiuqing del Rocio Sevilla Gonzalez, Magdalena Manning, Alisa Correa, Adolfo Meigs, James B. Taylor, Kent D. Rich, Stephen S. Goodarzi, Mark O. Rotter, Jerome I. Wilson, James G. Clish, Clary B. Gerszten, Robert E. Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title | Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title_full | Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title_fullStr | Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title_full_unstemmed | Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title_short | Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans |
title_sort | nontargeted and targeted metabolomic profiling reveals novel metabolite biomarkers of incident diabetes in african americans |
topic | Genetics/Genomes/Proteomics/Metabolomics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630088/ https://www.ncbi.nlm.nih.gov/pubmed/35998269 http://dx.doi.org/10.2337/db22-0033 |
work_keys_str_mv | AT chenzsuzsu nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT pachecojulianavila nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT gaoyan nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT dengshuliang nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT petersonbennet nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT shixu nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT zhengshuning nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT tahirusmana nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT katzdanielh nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT cruzdaniele nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT ngodebby nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT bensonmarkd nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT robbinsjeremym nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT guoxiuqing nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT delrociosevillagonzalezmagdalena nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT manningalisa nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT correaadolfo nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT meigsjamesb nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT taylorkentd nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT richstephens nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT goodarzimarko nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT rotterjeromei nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT wilsonjamesg nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT clishclaryb nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans AT gersztenroberte nontargetedandtargetedmetabolomicprofilingrevealsnovelmetabolitebiomarkersofincidentdiabetesinafricanamericans |